Zusammenfassung
Das Klimakterium stellt im Leben einer Frau eine Übergangsphase dar zwischen dem Erlöschen der Fortpflanzungsfähigkeit und dem Beginn der späten Postmenopause. Es umfaßt nach neueren Erkenntnissen etwa den Lebensabschnitt zwischen dem 47. und 55. Lebensjahr. Während dieser Zeit erlebt die Frau die letzte von den Eierstöcken gesteuerte Menstruationsblutung, die sog. Menopause. In Mitteleuropa tritt die Menopause durchschnittlich mit 51 Jahren ein. Ein Zeitraum von 5 Jahren vor dieser Menopause wird als Prämenopause bezeichnet, der Zeitraum ab 1 Jahr nach der Menopause heißt Postmenopause. Die Perimenopause stellt die Übergangsphase zwischen Prämenopause und Postmenopause dar, d. h. 2 Jahre vor der Menopause bis 1 Jahr danach.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aertgeerts J (1974). Wirkung oraler Östrogene auf die Haut der Frau in der Postmenopause und nach Kontrazeption. Ther Gegenw 113: 1739
Alffram PA, Bauer GCH (1962) Epidemiology of fractures of the forearm. J Bone Joint Surg 44-A: 105–114
Alhava EM, Puttinen J (1973) Fractures of the upper end of the femur as an index of senile osteoporosis in Finland. Ann Clin Res 5: 398–403
Andersch G, Hahn L (1985) Progesterone treatment of premenopausal tension — a double blind study. J Psychosom Res 29: 489
Andersch B, Wendestam C, Hahn L, Ohman R (1986) Premenstrual complaints. I. prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol 5: 39–49
Anderson I, Janzon L, Sigfusson BF (1985) Mammographie breast cancer screening — a randomized trial in Malmö, Sweden. Maturitas 7:21 — 29
Anderson E, Hamburger S, Liu JH, Rebar RW (1987) Characteristics of menopausal women seeking assistance. Am J Ob-stet Gynecol 156: 428–433
Arafat ES, Hargrove JT, Maxson WS, Desiderio DM, Wentz AC, Anderson RN (1988) Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am J Obstet Gynecol 159:1203 —1209
Aylward M (1976) Estrogens, plasma tryptophan levels in peri-menopausal patients. In: Campbell S (ed) The managment of the menopause and postmenopausal years. MTP Press, Lancaster, 135
Baker TG (1963) A quantitative and cytological study of germ cells in human ovaries. Proc Soc 158: 417–433
Ballinger CB (1975) Psychiatric morbidity and the menopause: Screening of general population sample. Br Med J 3: 344–346
Banzer D (1979) Quantitative Skelettdiagnostik bei demineralisierenden Osteopathien. Röntgenpraxis 32: 158–166
Basdevant A, de Lignieres B (1980) Treatment of menopause by topical administration of estradiol. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds) Percutaneous absorption of steroids. Academic Press, London, p 249
Batrinos ML, Panitsa-Faflia C, Pitoulis S et al (1979) The clinical features of the menopause and its relation to the length of pregnancies and lactation. Maturitas 1: 26–268
Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogenprogestin replacement. N Engl J Med 321: 293–297
Blair SN, Goodyear NN, Gibbons LW, Cooper KH (1984) Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 252: 487–490
Block E (1952) Quantitative morphological investigations of the follicular system in women: variation at different ages. Acta Anat (Basel) 14:108 —123
Brincat M, Moniz CF, Studd JWW, Darby AJ, Magos A, Cooper D (1983) Sex hormones and skin collagen content in postmenopausal women. Br Med J 287: 1337–1338
Bush TL (1991) Epidemiology of cardiovascular disease in women. In: Redmond GP (ed) Lipids and women’s health. Springer, New York Berlin Heidelberg Tokyo
Bush TL, Barret-Connor E, Cowan LD et al (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75: 1102–9
Butz S, Wüster C, Scheidt-Nave C, Götz M, Ziegler R (1993) Forearm BMD as measured by peripheral quantitative computed tomography (pQCT) in a German reference population. Osteoporosis Int 1993
Caniggia A (1984) The hormonal form of Vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis. J Endocrinol Invest 7/4:373 —378
Cardozo L, Gibb DMF, Tuck SM, Thom MH, Studd JWW, Cooper DJ (1984). The effects of subcutaneous hormone implants during the climacteric. Maturitas 5: 177–184
Caudron J, Hendrickx B (1988) Comparison of two equine oestrogen-dydrogestrone regimens in the climacteric. Maturitas 10:133 —141
Christensen MS. Hagen C. Christiansen C, Transböl I (1982) Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynaecologic and metabolic actions. Am J Obstet Gynaecol 144:873 —879
Christenson, CV, Gagnon JH (1965) Sexual behaviour in a group of older women. J Gerontol 20: 351–356
Christiansen C, Rus BJ (1990) 17ß-Estradiol and continous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 71: 836–841
Christiansen C, Christiansen MS, Transböl I (1981) Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet I: 459–461
Clarkson T (1992) Sex steroids and atherosclerosis in animal models. „Safty aspects of hormone replacement therapy“. International Symposium, 4–5 September, wells Medical Limited Copenhagen, pp 101–108
Coopen A, Wood K (1982) 5-Hydroxytryptamine in the pathogenesis of affective disorders. In: Ho BT, Schoolar JC, Us-din E (eds) Serotonin in biological psychiatry. Raven, New York, pp 249–259
Coulam CB (1981) Age, estrogens, and the psyche. Clin Obstet Gynecol 24:219 —229
Cummings S, Browner W, Grady D et al. (1990) Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? (Editorial) Ann Intern Med 113: 565–567
Curhan GC, Willett, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328: 833–838
Dambacher MA, Rüegsegger P (1985) Nichtinvasive Untersuchungsmethoden bei Osteoporosen. Ther Umsch 42: 339–350
Dambacher MA, Rüegsegger P, Demarmels MA, Fischer JA (1986) Pathogenesis and treatment of osteoporosis. In: Vaganakis A, Soucacos P, Avramides A et al (eds) Osteoporosis. Social and clinical aspects. 2nd International Conference on Osteoporosis. Masson Italia Editori, Mailand, pp 175 —194
Dambacher MA, pers. Mitteilung (1994)
Dennerstein L, Wood C, Burrows GD (1977) Sexual response following hysterectomy and oophorectomy. Obstet Gynecol 49:92— 96
Dequeker J, Roh YS, Dessel D, van Gautama K, Burssens A (1973) Bone mineral estimation in vivo by photon absorptiometry. Influence of skeletal size and its value for detecting osteoporosis. J Belge Med Phys Rhum 28: 293
Daring GK (1976) Klimakterische Beschwerden. Teil 1: Typische klimakterische Beschwerden. Fortschr Med 94:1058 —1061
Dupont WD, Page DL, Roger LW, Parl FF (1989) Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 63: 948–957
Edman LD (1983) The climacteric. In: Buchsbaum HJ (ed) The menopause. Springer, Berlin Heidelberg New York Tokyo, pp 77–84
Eggert-Kruse W, Runnebaum B, Kruse W (1990) Hormonprofile in der späten Postmenopause. In: Lauritzen C (Hrsg) Menopause, Hormonsubstitution heute 3. edition informed, München, S 18–25
Eriksen EF, Colvard DS, Berg NJ et al. (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84— 86
Ettinger B, Genant HK, Steiger P, Madvig P (1992) Low-doseage micronized 17ß-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 166: 479–488
Felsenberg D 1 991) Comparison of trabecular borie density at different anatomical sites: a prospective clinical study. (Vorgestellt bei der Jahrestagung der Radio! Soc North Am Chicago)
Gambrell RD (1978) The prevention of endometrial cancer in postmenopausal women with progestogens. Maturitas 1: 107–112
Gambrell RD (1986a) Prevention of endometrial cancer with progestogens. Maturitas 8: 159–168
Gambrell RD (1986b) Role of progestrons in the prevention ob breast cancer. Maturitas 8: 169–176
Gambrell RD, Maier RC, Sanders BI (1983) Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol 62:435 —443
Glatzner CM, Bailey I, Hull MGR (1985) Effectiveness of vaginal administration of progesterone. Br J Obstet Gynaecol 92: 364
Goldfarb AF, Daly MJ, Lieberman D, Reed DM (1970) Round- table: sex and menopause. Med Aspects Hum Sex 64
Gordan GS (1977) Postmenopausal osteoporosis, cause, prevention and treatment. In: Greenblatt RB, Studd J (eds) Clinics in obstetrics and gynaecology 4. Saunders, London, p 169
Gordan GS (1984) Prevention of bone loss and fractures in women. Maturitas 6:225–242
Gray LA, Christopherson WM, Hoover RN (1977) Estrogens and endometrial carcinoma. Obstet Gynecol 49: 385–389
Greenblatt R (1979) An endocrinologist comments on hormones for sexual dysfunction. Female Patient 4: 43–46
Gruber HE, Ivey JL, Baylink DJ, Matthews M, Help WB, Sisom K, Chesnut CH (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33: 295–304
Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA (1988) Postmenopausel use of estrogen and occlusion of coronary arteries. Am Heart J 115: 954–963
Hartge P, Hoover R, McGowan L, Lesher L, Norris HJ (1988) Menopause and ovarian cancer. Am J Epidemiol 127: 990 — 998
Henderson BE, Ross RK, Paganini-Hill A, Mack TM (1986) Estrogen use and cardiovascular disease. Am J Obstet Gynecol 154: 1181–6
Herrmann WM, Beach RC (1978) The psychotropic properties of estrogens. Pharmakopsychiatry 11: 164–176
Heuck F (1989) Qualitative und quantitative radiologische Analyse des Knochens. In: Dihlmann W, Frommhold W (Hrsg) Schinz — Radiologische Diagnostik in Klinik und Praxis, Bd 6 Thieme, Stuttgart, S 151–215
Hillard TC, Whitehead MI (1991) Hormon-Substitutionstherapie — Wege der Verabreichung In: Medical Communications Services (Hrsg) Kardiovaskuläre Wirkungen einer Hormonsubstitutionstherapie. Proceedings Internationales Novo Nordisk Symposium Kopenhagen, Dänemark, 1.-2. Februar 1991
von Holst T (1982) Hormonelle Diagnostik im Klimakterium der Frau. Habilitationsschrift, Ruprecht-Karls-Universitäts Heidelberg
von Holst T (1989) Nebennierenrindenfunktion in der Postmenopause und im Senium. In: Lauritzen C (Hrsg) Menopause, Hormonsubstitution heute 2. edition informed, München, S9–15
Horwitz RI, Stewart KR (1984) Effect of clinical features on the association of estrogens and breast cancer. Am J Med 76:192 —198
Huber J (1991) Substitutionstherapie im Klimakterium: Soll bei hysterektomierten Frauen auf Progestogene verzichtet werden? Geburtshilfe Frauenheilkd 51: 257–261
Hunt K, Vessey M, McPherson K, Coleman M (1987) Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 94: 620–635
Hunter MS (1990) Emotional well-being, sexual behaviour and hormone replacement therapy. Maturitas 12: 299–314
Husmann F (1993). Der vaso- und kardioprotektive Effekt der Östrogene. In: Schering AG, Pharma (Hrsg) Fachinformation zum Thema Klimakterium. Schering, Berlin
Janich H (1993) Die Älterenanteile in den Bundesländern und in den Gebietstypen: regionale Unterschiede in der Betroffenheit der Älteren durch die Einrichtung von Landes-AOK’s. In: Verband der Kriegs- und Wehrdienstopfer, Behinderten und Renter Deutschland, Landesverband Bayern e.V. (Hrsg) Vdk-Forum in der Evangelischen Akademie Tutzing am 17./18. 2. 1993
Judd HL (1976) Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 19: 775–788
Kaiser R (1984) Duration of the climacteric syndrome in women treated by hormonal substitution and in controls. Maturitas 5: 207–213
Kalender WA (1991) Abschätzung der effektiven Dosis bei Knochenmineralmessungen mit Photonenabsorptiometrie und Computertomographie. ROFO 155 /2: 149–154
Kampke D, Walcher W (1982) Physik für Mediziner. Teubner, Stuttgart
Kannei WB (1987) Metabolic risk factors for coronary artery disease in women: perspective from the Framingham study. Am Heart J 114: 413–9
Kannei WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 85: 447–452
van Keep PA, Kellerhals J (1974) Die älter werdende Frau. Therapiewoche 45:5170 — 5194
Kendell RE, Wainwright S, Hailey A, Shannon B ( 1976 The influence of childbirth on psychiatric morbidity. Psychol Med 6:297 —302
Krokowsky E (1974) Radiologie der Osteoporose. Therapiewoche 34: 3485 —3494
Kronenberg F, Cote LJ, Linkie DM, Dyrenfurth I, Downey JA (1984) Menopausal hot flashes: thermoregulatory, cardiovascular, and circulating catecholamine and LH changes. Maturitas 6: 3–43
Kuhl H, Taubert, H-D (1987) Das Klimakterium. Pathophysiologie, Klinik, Therapie. Thieme, Stuttgart
Lam SY, Baker HWG, Seeman E, Pepperell RJ (1988) Gynaecological disorders and risk factors in premenopausal women predisposing to osteoporosis: a review. Br J Obstet Gynaecol 95: 963–972
Lau EMC (1993) Hip fracture in Asia — trends, risk factors and prevention. In: Christiansen C, Riis B (eds) Proceedings 1993, Fourth International Symposium on Osteoporosis, Hong Kong. Aaalborg ApS, pp 58–61
Laufer LR, Erlik Y, Meldrum DR, Judd HL (1982) Defect of clonidine on hot flashes in postmenopausal women. Obstet Gynecol 60: 583
Lauritzen C (1975) Erfolge der hormonalen Therapie klimakterischer Beschwerden. Dtsch Ärzteblatt 9: 575–580
Lauritzen C (1978) Management of the patient at risk. Front Horm Res 5: 230–247
Lauritzen C (1980) Climacteric and obesity. I. Int Congress on Menopause and Obesity. Rome
Lauritzen C (1982) Treatment of menopausal symptons with low doses of clonidine. Dtsch Med Wochenschr 107 /9, 335–338
Lauritzen C (1987) Transdermal delivery of 17ß-estradiol. In: Lauritzen C (ed) Transdermal estrogen substitution. Huber, Bern, pp 82–83
Lauritzen C (1990a) Praktische Empfehlungen zur Östrogenprophylaxe in der Prä- und Postmenopause. Gynäkol Praxis 14:679— 688
Lauritzen C (1990b) Nichthormonale Therapie klimakterischer Beschwerden. Gynäkol Praxis 14: 43–56
Lievertz RW (1987) Pharmacology and pharmakinetics of estrogens. Am J Obstet Gynecol 156: 1289–1293
Lind T, Cameron EC, Hunter WM et al (1979) A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol [Suppl 3] 86:1— 29
Lindsay R, Tohme JF (1990) Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 76: 290–295
Lindsay R, Cosman F (1991) The risk of osteoporosis in aging women. In: Sitruk-Ware R, Utian WH (1991) The menopause and hormonal replacement therapy. Marcel Dekker, New York Basel Hong Kong, pp 47–72
Lobo RA (1990) Cardiovascular implications of estrogen re- placement therapy. Obstet Gynecol 75 [Suppl]: 18–25
Luine VN, Khylchevskaya RI, McEwen B (1975) Effect of gonodal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res 86:293 — 306
Marks R, Shahrad P (1976) Ageing and the effect of estrogen on the skin. In: Beard RS (ed) Menopause. MTP, Lancastert, pp 143–161
Marks R, Shahrad P (1977) Skin changes at the time of the climacteric. In: Greenblatt RBB, Studd J (ed) Clinics in Obstetrics and Gynaecology 4. Saunders, London, p 207
Marsh MS, Whitehead MI (1992) Managment of the menopause. Br Med Bull, vol 48: 426–458
Mattingly RF, Huang WY (1969) Steroidogenesis of the menopausal and postmenopausal ovary. Am J Obstet Gynecol 103:679 — 693
Mattson LA, Cullberg G, Samsioe G (1982) Evaluation of a continous oestrogen-progesteron regimen for climacteric complaints. Maturitas 4: 95–102
Mc Broon JR, Hayes WC, Edwards WT, Goldberg RP, White III AA (1985) Prediction of vertebral body compression fracture using quantitative computed tomography. J Bone Joint Surg 67: 1206–1214
McEwen BS, Biegon A, Fischette CT, Luine VN, Parsons B, Rainbow TC (1984) Towards a neurochemical basis of steroid hormone action. In: Martini L, Ganong W (eds) Frontiers in neuroendocrinology. Raven, New York, pp 1153–1176
McEwen BS (1991) Steroid hormones are multifunctional mes- sengers to the brain. Trends Endocrinol Metab 2: 62–67
McGregor GA, Best FE, Cam JM et al (1982) Double-blind randomized cross-over trial of moderate sodium restriction in essential hypertension. Lancet 1: 351
Meema S, Meema HE (1976) Menopausal bone loss and estrogen replacement. Isr J Med Sci 12: 601–604
Melchert F (1987) Comparative clinical study of Estraderm TTS and Presomen (Premarin) in patients with postmenopausal syndrome. 5th International Congress on the Menopause, Sorrent, April 6–10, Panthenon Publishing, Sorrent, Abstr. 98; p 120
Minne HW, Leidig G, Wüster CHR et al (1988) A newly developed spine deformity index ( SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner 3: 335–349
Meuwissen JHJM, van Langen H, Nielen M (1992) Endometriumwachstum während kontinuierlicher, alleiniger Östrogensubstitutionstherapie mit Estraderm TTS (0,05 mg/die) bei 31 postmenopausalen Frauen. Geburtshilfe Frauenheilkd 52:351— 354
Muck AO (1990) Transdermales Therapeutisches System zur physiologischen Östrogensubstitution. Therapiewoche 40:41— 51
Muck AO, Weber E, Blümner EG, Lippert TH (1994) Transdermale Östrogensubstitution — eine multizentrische Studie mit 15194 Patienten. Münchner Med Wochenschr 136:35 —40
Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckmann EM (1979) Estrogen replacement therapy. I. 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 53:277 — 281
Nachtigall LE, Nachtigall NJ, Smilen SW, Nachtigall RH, Nachtigall RH (1993) Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement. (Vortrag 7. Weltkongress Menopause, Stockholm, Schweden) Abstr # 9, p 8
Neugarten BL, Krainer RJ (1965) Menopausal symptoms in women of various ages. Psychosom Med 27:266–273 Nordin BEC (1980) The prevention of postmenopausal osteoporosis. Eur J Clin Invest 10 /4: 259–260
Osmers R, Völksen M, Rath W, Teichmann A, Kuhn W (1989) Vaginosonographische Messungen des postmenopausalen Endometriums zur Früherkennung des Endometriumkarzinoms Geburtshilfe Frauenheilkd 49: 262–265s
Ott SM, Chesnut III CH (1987) Calcitriol treatment in patients with postmenopausal osteoporosis. In: Christiansen C, Johansen JS, Riis BJ (ed) Osteoporosis. Proceedings of the International Symposium on Osteoporosis, September 27-October 2, 1987. Osteopress 2: 844–849
Ott SM, Kilnoyne RF, Chesnut CH (1987) Ability of four different techniques of measuring bone mass to diagnose vertebral fractures in postmenopausal women. J Bone Miner Res 2:201— 210
Owen EJ, Siddle NC, McGarrigle T, Pugh MA (1989) Choosing the optimum dose of oestradiol implant — pharmacokinetics and symptom relief with 25 mg oestradiol implantation. Br Soc Obstet Gynaecol, London
Paffenberger RS, Wing AL, Hyde RT, Jung DL (1983). Physical activity and incidence of hypertension in college alumni. Am J Epidemiol, 117: 245–257.
Paterson MEL, Wade-Evans T, Sturdee DW, Thom MH, Studd JWW (1980) Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J I:822 — 824
Plouffe L, Nolan JR TE, Speroff L, Lorrain J (1993) Continuing medical care of the menopausal woman In: Lorrain J, Plouffe L, Ravnikar Jr V, Speroff L, Watts N (eds) Comprehensive management of menopause, p 384
Possinger K, Classen S, Beykirch M, Flath B, Wilmanns W (1991) Hormontherapie beim metastasierten Mammakarzinom der Frau. Dtsch Med Wochenschr 116: 1921–1929
Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC (1985) Pharmakokinetics and pharmacodynamics of trans-dermal dosage forms of 17ß-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 152: 1099–1106
Rabe TH (1990) Gynäkologie und Geburtshilfe. Ed. Medizin, VHC, Weinheim
Rauramo L, Punnonen R (1973). Die Wirkung von Kastration und oraler Östrogentherapie auf die Haut der Frau. In: van Keep PA, Lauritzen C (Hrsg) Älter werden und Östrogene. Karger, Basel, S 51
Recker RR (1993) Skeletal physiology: growth and aging. In: Lorrain J, Plouffe L, Ravnikar Jr V, Speroff L, Watts N (eds) Comprehensive management of menopause. pp 24
Reginald PW, Adams J, Franks S, Wadsworth J, Beard RW (1989) Medroxyprogesterone acetate in the treatment of pelvic pain due to venous congestion. Br J Obstet Gynaecol 96: 1148
Reiners C (1991) Nicht-invasive quantitative Knochendichtebestimmung: In: Ringe JD (Hrsg) Osteoporose. de Gruyter, Berlin, S 157–216
Riedel M, Rafflenbeul W (1992) Estrogens and cardiovascular diseases in postmenopausal women. Dtsch Med Wochenschr 117/31–32: 1205–1211
Riggs BL, Hodgson S, O’Fallon W, Chao E, Wahner H, Muhs J, Cedel S, Melton LJ III (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322: 802–9
Riggs BL, O’Fallon W, Hodgson S, Chao E, Wahner H, Muhs J, Melton L (1992) Clinical trial of fluoride in osteoporotic women: extented observation and additional analyses.
Ringe JD (1993) Indzidenz der Osteoporosefaktoren steigt weiter. Dtsch Ärztezeitung, S 14
Rosemeier, Schultz-Zehden, pers. Mitteilung, 1993
Rüegsegger P (1991) Einsatz der Knochendichtemessung in der Diagnostik und der Therapie der Osteoporose. Ther Umsch 48: 113–119
Rüegsegger P, Durand EP, Dambacher MA (1991a) Differential effects of ageing and disease on trabecular and compact bone density of the radius. Bone 12: 99–105
Rüegsegger P, Durand E, Dambacher MA (1991b) Localisation of regional forearm bone loss from high resolution computed tomographic images. Osteoporosis Int 1:76 — 80
Runnebaum B, Salbach B, von Holst Th (1994) Orale oder transdermale Östrogensubstitutionstherapie im Klimakterium? Geb Fra 54:119— 130
Rylance PB, Brincat M, Lafferty K, De Trafford JC, Brincat S, Parsons V, Studd JWW (1985) Natural progesterone and antihypertensive action. Br Med J 290: 13
Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Esiman J (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328: 1747–1752
Schenkel L (1985) TTS-Estradiol zur physiologischen Hormonsubstitution in der Menopause. Schweiz Rundsch Med (Praxis) 74: 277–282
Schiff I, Komarov Sela H, Cramer D, Tulchinsky D, Ryan KJ (1982) Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 37: 79–82
Schneider HPG, Dören M (1993) Osteoporose aus gynäkologischer Sicht. Gynäkologe 26: 83–92
Schneider P, Börner W (1990) Indikationen zur Knochendichtemessung und kritische Bewertung. Nuklearmediziner 13: 83–91
Schneider P, Börner W (1991) Prediction of vertebral crush fractures in postmenopausal women with peripheral QCT in comparison to DEXA of the spine. Osteoporosis Int 1: 210 (abstract)
Schneider P, Berger P, Moll E (1985) Getrennte Messung von Kompakta- und Spongiosadichte mit einem Transverdal-Rotations-Scanner. ROFO 143:178 —182
Schneider P, Börner W, Mazess RB, Barden H (1988) The relationship of peripheral to axial bone density. Bone Miner 4:279— 87
Schrage R (1985) Therapie des klimakterischen Syndroms. Edition Medizin, Weinheim, S 5–93
Seibel MJ, Robins SP, Bilezikian JP (1992) Urinary pyridnium crosslinks of collagen. Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 4:283 — 291
Shangold MM (1983) Sports and exercise. In: Buchsbaum HJ (ed) The menopause. Springer, Berlin Heidelberg New York Tokyo, pp 199 — 203
Sherman BM, West JH, Korenman SG (1976) The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42: 629–636
Sherwin BB (1991a) The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72: 336–343
Sherwin BB (1991b) Estrogen and Refractory Depression. Adv Neuropsychiatry Psychopharmacol 2:209 —218
Smith P (1972) Age changes on the female urethra. Br J Urol 44: 667 — 676
Staland B (1981) Continous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas 3:145 —156
Stampfer MJ, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence. Prey Med 20: 47–63
Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA, Lobo RA (1988) A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol 159: 1540–1569
Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265: 1985 —1990
Stevenson JC, Abeyasekera G, Hillyard CJ, Phang KG, McIntyre I, Campbell S, Townsend PT, Young O, Whitehead MI (1981) Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet 1981/1:693 — 695
Stevenson JC, White MC, Choplin GF, Macintyre I (1982) Osteoporosis and calcitonin deficiency. Br Med J 285: 1010–1015
Storm T, Thamsborg G, Steiniche T, Genant H, Sorensen OH (1990) Effect of intermittant cyclical etidronate on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322: 1265–71
Strecker JR (1990) Physiologische Abläufe im Klimakterium. In: Wolf AS, Schneider HPG (Hrsg) Östrogene in Diagnostik and Therapie. Springer, Berlin Heidelberg New York Tokyo, S 67 —76
Strecker JR, Lauritzen C (1992) Praxis der Hormonbehandlung im Klimakterium. Enke, Stuttgart ( Bücherei des Frauenarztes, Bd 29 )
Studd JWW, Collins WP, Chkavarti S, Newton JR, Oram D, Parson A (1977) Estradiol and testosterone implants in treatment of psychosexual problems in postmenopausal women. Br J Obstet Gynaecol 84: 314–315
Sturdee DW, Wade-Evans T, Paterson MEL, Thom M, Studd JWW (1978) Relations between bleeding pattern, endometrial history, and oestrogen treatment in menopausal women. Br Med J L•1575–1577
Sullivan JM, Vander Zwaag R, Hughes JP et al (1990) Estrogen replacement and coronary heart disease Arch Intern Med 150: 2557–62
Taggart HM, Chesnut CH, Ivey JL, Baylink DJ, Sisom K, Huber HB, Roos BA (1985) Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis. Lancet I:475 — 480
Teoh ES, Teoh LKK (1991) Improving the quality of life after 45. In: Teoh ES, Ratnam SS (eds) The future of gynaecology and obstetrics. Parthenon, Casterton Hall, Carnforth, Lancs., UK
Thomas DB, Chu J (1986) Nutritional and endocrine factors in reproductive organ cancer: Opportunities for primary prevention. J Chron Dis 39: 1031–1050
Tiegs RD, Body IJ, Wahner HW, Barta J, Riggs BL, Health III H (1985) Calcitonin secretion in postmenopausal osteoporosis. New Engl Med 312: 1097–1100
Tilyard MW, Spears GFS, Thompson J, Dovey S (1992) Treatment of osteoporosis with calcitriol or calcium. N Engl J Med 326: 357–62
Tulandi T, Lal S, Kinch RH (1983) Effect of intravenous clonidine on menopausal flashing and luteinizing hormone secretion. Br J Obstet Gynaecol 90: 854
Utian WH (1978) Effects of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight. Maturitas 1: 3–8
van Keep PA, Greenblatt RB, Albeauch-Fernet M (eds) (1976) Consensus on menopause research. MTP Press, Lancaster
Vermeulen A (1976a) Postmenopausal ovarian function. In: James VHT, Serio M, Gusti G (Eds): The endocrine function of the human ovary. Academic Press, London New York San Francisco
Vermeulen A (1976b) The hormonal activity of the postmenopausal ovary. J Clin Endocr 42: 247–253
Vermeulen A (1980) Sex hormone status of the postmenopausal woman. Maturitas 3: 81–89
Voda AM (1981) Climacteric hot flash. Maturitas 3: 73–90
Von Stetten EC, Steiger P, Kelly L, Stein JA (1991) Paired a.p. and lateral spine dual x-ray absorptiometry improves precision of repeat lateral scans. J Bone Miner Res 6 [Supp11]: 171
Warren MP, Brooks-Gunn J, Hamilton LH, Warren LF, Hamilton WG (1986) Scoliosis and fractures in young ballet dancers. Releation to delayed menarche and secondary amenorrhea. N Engl J Med 314: 1348–1353
Wasnich RD, Ross PD, Heilbrun LK, Vogel JM (1985) Prediction of postmenopausal fracture risk with use of bone mineral measurements. Am J Obstet Gynecol 153: 745–751
Watts NB, Harris S, Genant HK et al (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323: 73–79
Weigel M, Schmitt W, Lieder H-J, Inthraphuvasak J (1990) Die Wertigkeit verschiedener Parameter zur sonographischen Beurteilung des postmenopausalen Endometriums hinsichtlich benigner und maligner Neoplasien. Geburtshilfe Frauenheilkd 50: 870–876
Winokur G (1973) Depression in the menopause. Am J Psychiatry 130: 92–93
Whitehead MI (1986) Prevention of endometrial abnormalities. Acta Obstet Gynecol Scand [Suppl] 134: 81–91
Wüster CHR, Duckeck G, Ugurel A, Lojen M, Minne HW, Ziegler R (1990) Increased sensitivity of bone mass measurements by inclusion of body height and surface. In: Christiansen C, Overgaard K (eds) Osteoporosis, Osteopress ApS, Copenhagen, pp 623–625
Wüster CHR, Schurr W, Scharla S, Raue F, Minne HW, Ziegler R (1991) Superior tolerability of human versus salmon calcitonin preparations in young healthy volunteers. J Eur Clin Pharmacol 41: 211–215
Wüster CHR, Duckeck G, Ugurel A, Lojen M, Minne HW, Ziegler R (1992) Bone mineral content of spine and forearm in osteoporosis and in German normals: influences of sex, age and anthropometric parameters. Eur J Clin Invest 22: 366–370
Ziegler R (1982). Hormonale Behandlung und Prophylaxe der Osteoporose. In: HPG Schneider (Hrsg) Klimakerium der Frau. Seminar anläßlich des Kongresses für ärztliche Fortbildung, Berlin, 2. Juni 1982
Zürcher Gesprächskreis (1994) Dt. Ärzteblatt 91: 11
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Runnebaum, B., Rabe, T., v. Holst, T., Wüster, C. (1994). Klimakterium der Frau. In: Gynäkologische Endokrinologie und Fortpflanzungsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07635-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-07635-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07636-1
Online ISBN: 978-3-662-07635-4
eBook Packages: Springer Book Archive